$MRNA News

Moderna Facing Several Vaccine Headwinds in Near, Medium Term, RBC Says

Citigroup Maintains Neutral on Moderna, Raises Price Target to $60

Moderna (MRNA) Faces Norovirus Setback As MFLUSIVA FDA Decision Nears

Moderna Inc (MRNA) (Q2 2026) Earnings Call Highlights: Revenue Beat and Pipeline Progress Amid ...

Moderna Q2 earnings beat estimates as norovirus vaccine stumbles

Moderna Q2 Earnings Call Highlights

Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates

Moderna, Inc. (MRNA) Q2 2026 Earnings Call Transcript

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna Burns Cash, Suffers Fresh Vaccine Setback

Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Moderna Q2: Weak Revenue, Strong Pipeline - Here's What Matters Now

Moderna Affirms FY2026 Sales Guidance of $2.138B vs $2.089B Est

Moderna (MRNA) Q2 Earnings: What To Expect

Moderna (MRNA) Stock May Be Overvalued After Cancer Trial Start

Moderna Stock Has Doubled in 2026, But Wall Street Still Isn’t Convinced

Why Moderna (MRNA) Is Down 6.5% After Europe Clears Its First Flu-COVID Combo Vaccine

2 Major Reasons to Buy Moderna Stock Before July 31

Q1 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks